chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was scheduled in Clinic to receive 2nd dose of Pfizer. Both Pfizer and Moderna orders were in the chart and signed by the PCP on 10/1/21. CMA checked the Covid vaccine screening form and noticed patient had checked both Pfizer and Moderna for the verification on which vaccine had been given for the first dose. CMA checked the chart to make sure that the order was in the chart. CMA verified with patient that she was here for 2nd dose Pfizer. Patient said yes and CMA administered the Pfizer. After administration, it was noticed on the CDC card the patient had that the first vaccine had been a Moderna. Patient then denied having confirmed she was here for Pfizer after CMA notified her of the mistake. CMA Supervisors verified in the patient chart and system that patient did receive Moderna vaccine. No adverse events were noticed at this time.
Pt reports feeling fuzzy (mental clarity wise) and a buzzing feeling since receiving  Pfizer COVID-19 vaccine #1. Pt reports after receiving Pfizer COVID-19 vaccine #2, buzzing has gotten slightly worse. Pt reports when she takes a deep breath it causes her breath to catch and for her to cough. Pt reports no SOB or difficulty breathing.
Expired vaccine used; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 17-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.            No treatment information was provided. This is a spontaneous case that reports EXPIRED PRODUCT ADMINISTERED to a patient of  unknown age and gender who received mRNA-1273 ( (batch no. 029A21A) on 17 -Jul-2021. There was not any associated adverse event reported. The benefit-risk relationship of mRNA-1273  is not affected by this report.; Sender's Comments: This is a spontaneous case that reports EXPIRED PRODUCT ADMINISTERED to a patient of  unknown age and gender who received mRNA-1273 ( (batch no. 029A21A) on 17 -Jul-2021. There was not any associated adverse event reported. The benefit-risk relationship of mRNA-1273  is not affected by this report.
Eleven (11) days after 2nd dose, nearly fainted on driveway after standing in sun too long and discussing medical issues.  Called advise nurse and was advised to visit emergency department.  Past medical history pertinent for hypertryglyceridemia, elevated BMI presenting to the ED with complaint of SYNCOPE (Pt. was talking with his parents about 'medical' stuff, and felt a little queezy, had brief near syncope episode, no full LOC.  Scraped arm on a brick wall during episode as fell to ground)
Patient reported being dizzy 2 minutes after vaccination. Upon going out and attending to patient, eyes starting rolling a bit and patient shook awkwardly a few times..as if was about to slip to unconsciousness.  Tapping patient and repeating name she came out of this very shortly (4 seconds or so), and stated feeling lightheaded and dizzy.  Patient was brought water, a cold pad, and some crackers and had her feet elevated . Patient was continuously monitored and continued to improve after initial episode.  Blood pressure was taken twice during event, and was 109/61 and 109/62.
Chills - This is the first symptom I noticed. I received the shot around 3:30pm and by 7-8pm that night I started to get chills/sweats. That lasted for about a day and a half.  Pain at the injection site - on day three and it is now a slight pain/soreness.  Headache - lasted two days.  Very Tired - lasted about two days.  Muscle aches and stiffness in neck - lasted about two days.  Nausea - was mostly on the second day after shot when I noticed it the most.
This spontaneous report was received from a physician via a company representative, referring to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 04-MAR-2015, the patient was vaccinated with the improperly stored dose of PNEUMOVAX 23 "10 PK 0.5 ml SD-PFS LLok wTip" lot number K009106 with expiration date of 25-FEB-2016 (dose number, route of administration and anatomical location were not provided), which was stored at -2.77 Celsius Degrees for 336 hours. The type of excursion was refrigerator. No adverse effects were reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
Pain in my left hand joints and knuckles.  Sudden onset when I was driving home after receiving the vaccine.  Today is August 3, 2021 and I still have daily pain in my left hand.
Symptoms: fever, left armpit pain, sore throat, headache, joint pain, chills, burning when urinating, nausea. Two days in bed. Total rest. Day 3 (today) I feel better. Still slight armpit pain, inappetent, confused. I understand that by the nature of the new variants the dose is stronger. I just wanted to be part of the documentation. Thanks
Painful right arm after influenza vaccination. 6 weeks duration - treated area with ice and anti-inflammatories. Had a high dose vaccine the prior year without adverse effects.
Patient states that she had the 1st dose of the COVID-19 vaccine on 1/11/21 at work. Noticed pain in arms when she woke the next morning. Most severe in the mornings, but aches all day. Patient said her arms feel like lead in the morning. She is also reporting knee joint pain. She has a lump at the vaccine sight, that is raised and very itchy. She is also reporting increased fatigue, and has missed work. Patient reported to rheumatologist's office this day reporting, and was directed to use supportive measures (ibuprofen, diphenhydramine, acetaminophen), and to notify us if symptoms worsen or persist.
HYPOTENSION 1/7/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Two days post vax pt was seen in ER for rash under arms and upper torso. Pt was treated with a steroid injection. Four days later pt was seen again in the ER and given IV steroids and Medrol.
Rash on R lower extremity approx 2-3 weeks following second injection. Attempted OTC treatments for several weeks. Received 2 total rounds of orals steroids, followed by topical steroids. Rash still present on leg. Skin is irritated, red, severe itching.  Scabbing in area of active rash, and scarring in places where rash has healed.
Arm became inflamed after injection; This is a spontaneous report from a contactable physician via Pfizer sales representative. A female patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13; Solution for injection in pre-filled syringe) via unspecified route of administration in the arm on unspecified date at single dose for immunization. Patient had no relevant medical history (none). Concomitant medications were not reported. The physician reported that a patient received a dose of pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein); and patient arm became very inflamed after injection on unspecified date. She went back to the office a week later and she was fine. Outcome of the event was reported as recovering.  Information on batch number has been requested.
numbness and muscle twitches in left face (similar symptoms to Bell's palsy, which individual had 5-6 years ago)
Seven hours after I got the vaccine, I got a severe headache. It lasted all night and into the next day. I called the Nurse and she told me it might last two days. I tried multiple pain killers, and nothing worked. After twenty four hours I had a pressure sensation in my head. My normal Migraines cause dizziness. This time my head felt very full and it lasted 24 hours. On the third day I started to get light-headed ,and it lasted all day. Four days after the vaccine I started to get a more general headache and it lasted all day and it came and went for a few more days. Ice packs worked to relieve the pain with Aleve. I did not feel normal for twelve days after the vaccine.
I went camping with some friends on Thursday 06/09/22. I didn't feel or notice any symptoms until Saturday, 06/11/2022 in the  evening around 6pm. I needed a nap which is unusual for me. I went in to take a nap, but ended up sleeping all night. I drove home the next day and was extremely fatigued. I almost fell asleep 3 times while driving. I thought it was just allergies so I took a ZYRTEC. When I returned home I tested myself for Covid and was positive. I called the on call doctor and was prescribed PAXLOVID that same day. My symptoms began to improve by the following Tuesday. I am still experiencing fatigue but it is much better than before.
pt exp pain & swelling @ inject site; pt apparently crying for several hrs p/inject, only sl rt ear infect;
Information has been received from a physician and healthcare worker concerning a 21 year old female who was vaccinated on 17-JAN-2008 in the left deltoid with her third dose of GARDASIL (lot# 659441/1446U). Concomitant therapy included YAZ. On 17-JAN-2008 the patient felt achy, had a high fever, headache and the chills after receiving her third dose. Subsequently, the patient recovered on 18-JAN-2008 from feeling achy, a high fever, headache and chills. The patient sought unspecified medical attention on an unspecified date. No additional information is expected. This is a consolidation of two reports.
Left side of head swelled post DTaP (1) asymmetrical, intermittent streaks of blood in stool for 4-6 weeks.
High grade fever (101°) beginning 3/24/21 around 8pm, runny nose, breathing difficulties, sore throat, headache not responding completely to Tylenol or ibuprofen, tachycardia 90-115 BPM despite taking corlanor as prescribed, exhaustion, body aches, chills
This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. Information regarding medical history, concurrent conditions, drug reactions or allergies was not reported. On 20-JUL-2016, the patient was inadvertently vaccinated with an expired dose of PROQUAD, (dose, route of administration, and frequency were not provided) with lot # K021548, expiration date 06-MAY-2016. There were not concomitant therapies reported. No adverse event was produced. No product quality complaint was involved. Additional information has been requested.
Information was received on 25-JUL-2017 from a lawyer regarding a case in litigation concerning a female patient of unknown age. On 24-JUL-2014, the patient received a dose of ZOSTAVAX vaccine for it's intended purpose, the prevention of shingles. On 09-SEP-2015, the patient visited an eye doctor for complaints of a black line and blurriness in her eye. The patient was diagnosed with acute retinal necrosis and laboratory testing was conducted to determine the cause. Laboratory results were positive for herpes zoster and the patient's physician diagnosed this as the cause of the problem with her retina. The patient subsequently experienced retinal detachment and has undergone multiple surgical procedures in an attempt to repair the injury, an injury that continued to this day. As a direct and proximate result of the defective ZOSTAVAX vaccine, the patient's symptoms have resulted in physical limitations not present prior to using ZOSTAVAX. The patient also experiences mental and emotional distress due to resulting physical limitations from, and seriousness of, her condition. The patient sustained severe and permanent personal injuries. Further,  the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The patient has incurred and will continue to incur medical expenses and other economic harm as a direct result of use of ZOSTAVAX. Upon internal review, acute retinal necrosis positive for herpes zoster and retinal detachment were considered medically significant. Acute retinal necrosis positive for herpes zoster and retinal detachment were disabling. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to a 5 year old male patient. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 18-SEP-2017, the patient was vaccinated with improperly stored PROQUAD lot # M036295, expiration date 13-FEB-2018, (strength, dose, dose number and route of administration were not provided) for prophylaxis (incorrect product storage). The vaccines were reconstituted with properly stored doses of sterile diluent (MERCK STERILE DILUENT). The vaccines were exposed to temperature range of 6 degree Fahrenheit (F) to 14 degree F for 1 hour and 20 minutes. This report was because of a digital data logger. There was no previous temperature excursion. No adverse effects were reported. Product quality complaint was not involved. This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1709USA008861:
arm was sore; bumped her head and got a little bruise on her temple; bumped her head and got a little bruise on her temple; The spot has changed over to a little bit of a rash and it has some neuralgia and peeling; The spot has changed over to a little bit of a rash and it has some neuralgia and peeling; The spot has changed over to a little bit of a rash and it has some neuralgia and peeling; This is a spontaneous report received from a contactable consumer (patient). A 68-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 19Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient experienced her arm was sore half a day.  About a week later she thought she bumped her head and got a little bruise on her temple and it hadn't gone away. The spot had changed over to a little bit of a rash and it had some neuralgia and peeling. The outcome was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pfizer vaccine was reconstituted with sterile water instead of normal saline and administered.  The patient has not reported any adverse effects at this time.
Pt came to our office and received 1st dose of SHINGRIX vaccine at approx 11 AM on 3/30/19. Pt states that by the evennig on 3/30/19 she developed "shaking chills", severe headache, flu like body aches, injection site pain. Fever - took TYLENOL to relieve symptoms before taking temp. Highest temp she got on the thermometer was 99.0 F orally. Pt does have a history of asthma but did state that she had some issues with wheezing but did not have any issue before getting SHINGRIX vaccine. Pt states that the shaking chills and fever symptoms last 1.5 days. She is still having issues with injection site pain/weakness, headache, and muscle aches 4 days post vaccination. Pt reported concerns to RN Care Manager out of concern for meeting a new granddaughter and the length of the side effects. Information was called to PCP office manager to report to PCP.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 09-AUG-2014 the patient was received expired PNEUMOVAX23 (25/0.5 Y) (lot # H022280, expiry: 16-JUL-2014, dose and route of administration was unknown). Pertinent medical history and concomitant medications were unspecified by the reporter. The reporter stated that PNEUMOVAX23 did not have any temperature excursions. The reporter also stated PNEUMOVAX23 supported with in-house stability data. No adverse symptoms reported. The outcome of the events was unknown. No further information provided. Additional information has been requested.
Pt presented to office with erythematous papilar rash approximately 48 hours after receiving his second dose of Covid vaccine. Pt's first dose was 3/20/21 and pt denied any adverse events with that dose. Rash began on trunk and was spreading to neck and down arms. Pt denied any other symtoms and was afebrile. A punch biopsy was taken and pt was advised to take benedryl and call with any other symptoms. Pt was seen 1 wk and 2 wks for f/u. At 1 wk f/u pt stated that rash had resolved approximately 48 hours after being seen in office. Biposy showed urticarial dermatitis.
Information has been received from a pharmacist concerning a patient who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. The pharmacist reported a physician requested specific treatment that is recommended for an injection site reaction following vaccination with pneumococcal 23v polysaccharide vaccine. No other patient or lot information was available, There was no product quality complaint reported. Unspecified medical attention was sought. Additional information has been requested.
Tested positive of Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive of Covid-19) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive of Covid-19). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive of Covid-19) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information use was not reported.  Treatment information was not provided.    Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Events Outcome: from unknown to recovered updated.
Developed macular lesions on both upper legs, where vaccines were given, 2 days post vaccination. ATARAX syrup 10 mg/5ml : 3/4 tsp PO Q8-12 hrs prn for itchy rash.
Mild headache started at 10:00 PM on 1/25/21.  In the morning around 6:30 am, 1/26/21, fever of 99.5, body aches, fatigue, no appetite.  At 11:30 am, fever up to 100.9.  8:00 PM on 1/26/21, fever was up to 103.2, severe body aches continued, was in bed all day long, felt like she was dying.  Today, 1/27/21, diarrhea.  Fever has resolved, no body aches, no headaches, just the diarrhea.   Did not take her Tylenol on Monday due to conflicted reports, but did take Tylenol when her fever got up to 100 and continued to take it every 6 hours and is continuing that now.
Received Heplisav-B While Pregnant; Initial Report Received on 18-Apr-2023   A registered nurse manager reported that a 39-year-old pregnant female patient (race and ethnicity unknown) was inadvertently given a dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis?B immunization.    Medical history, allergies, and concomitant medications at the time of vaccination were not reported.    On 14-Apr-2023, the pregnant patient received the first dose of HEPLISAV-B vaccine (Lot # 941580, expiration date 29-Nov-2024, and NDC # 43528-0003-05) intramuscularly in the left deltoid from a nurse. The number of weeks gestation was unknown, and the patient's last menstrual period was on 07Oct-2022. The patient came into the facility with immigration paperwork to give vaccines. This incident was discovered upon an audit on 18-Apr-2023. The nurse manager will call to notify the patient and provide the pregnancy registry information. No adverse reactions were reported.   No additional information was provided.   Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
COPD; has tested positive for COVID currently; has tested positive for COVID currently; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date Mar2021 (Batch/Lot number: unknown) as dose 2, single and administration date Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2021, outcome "not recovered" and all described as "has tested positive for COVID currently"; CHRONIC OBSTRUCTIVE PULMONARY DISEASE (non-serious), outcome "not recovered", described as "COPD". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (2021) positive. Therapeutic measures were taken as a result of chronic obstructive pulmonary disease. The patient tested positive for COVID currently and that he found out on the morning of reporting that he had COVID and he drives a school bus and plays ball every other Saturday so he could have gotten from there. Patient stated that he just wanted to get something for treatment because he had COPD and was worried about his breathing. His breathing was fine at the time of reporting as he got a steroid shot of Decadron that morning and he had to get some other stuff. The patient was just scared.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Complaints of asthma like symptoms after receiving vaccine, tachycardia, feeling 'funny'.  Used rescue inhaler for shortness of breath.
muscle aches; Joint pain; Tingling; Fatigue; Little more stiff; sore than usual; This is a spontaneous report from a contactable nurse.  A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date at SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 and she had "incredible fatigue, and body aches followed with a headache" for about 24 hours.  Five hours after second dose, the patient experienced muscle aches, joint pain, tingling, and fatigue lasted about 30 hours- it has resolved just a little more stiff /sore than usual. The outcome of the events little more stiff, and sore was unknown while recovered for the other events.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Fever, chills, bloodshot eyes, extreme fatigue, swollen lymph nodes (mostly left side), swollen sore left arm
Developed right arm redness the size of 50 cent piece (according to mom) approx. 3 hours after vaccination. She gave TYLENOL at that time, again that night and the morning of 5/19/15. Was warm to touch. No hardness noted when nurse asked mother. On 5/21/15 mom says redness remains same size around injection site. She has slight appetite decrease, otherwise well.
Within 5-10 hours of the second dose: nausea, vomiting, chills, fever, fatigue. Chills, fatigue and nausea continued for 10 days until death
pt came back to pharmacy within 15 minutes to complain of racing heart, difficulties breathing, sweating, feeling hot, right sided facial numbness, and dizziness.  EMS called to evaluate pt. pt and husband state she has issues with anxiety and these events feel similar to a panic attack/anxiety.  Pt given water. EMS determined pt stable and pt chose not to leave with EMS for further evaluation. Pt remained in consultation room for 5 minutes after EMS left and left with her husband when she felt ready.